Treatment of anxiety in autistic adults: A systematic review / Michelle MENEZES in Research in Autism Spectrum Disorders, 99 (November)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 99 (November) . - 102068 Titre : Treatment of anxiety in autistic adults: A systematic review Type de document : Texte imprimé et/ou numérique Auteurs : Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Jessica PAPPAGIANOPOULOS, Auteur ; Robert CROSS, Auteur ; Roma A. VASA, Auteur ; Micah O. MAZUREK, Auteur Article en page(s) : 102068 Langues : Anglais (eng) Mots-clés : Autism  ASD  Anxiety  Mental health  Treatment Index. décimale : PER Périodiques Résumé : Background Autistic adults are more likely than adults without autism spectrum disorder (ASD) to experience clinically significant anxiety. In addition, anxiety in autistic adults is associated with poorer quality of life and myriad negative outcomes (e.g., unemployment, suicidality). Therefore, this systematic review aimed to summarize and evaluate the literature on the psychotherapeutic and psychopharmacological treatment of anxiety in autistic adults to inform clinical decision-making. Method Several online databases were searched for peer-reviewed journal articles with any combination of the following terms in the abstract: (1) autism, autistic, Asperger, Asperger’s, or œpervasive developmental disorder � (2) anxiety, anxious, phobia, mutism, panic, agoraphobia, or worry and (3) treatment, intervention, trial, therapy, psychotherapy, pharmacotherapy, medication, drug, antidepressant, sedative, or anti-anxiety. Data were extracted from articles meeting the inclusion criteria, and the strength of the evidence was assessed for treatments. Results Fifteen psychosocial treatment studies, one pharmacological treatment study, and one combined psychosocial and pharmacological treatment study met the inclusion criteria. The most investigated treatment for anxiety in adults with ASD was cognitive behavioral therapy (CBT). Conclusions Few studies have investigated the treatment of anxiety in autistic adults. Additionally, findings have been inconsistent across studies regarding the potential effectiveness of particular psychosocial and pharmacological treatments. More research is certainly needed before clinically useful conclusions can be made. En ligne : https://doi.org/10.1016/j.rasd.2022.102068 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=491 [article] Treatment of anxiety in autistic adults: A systematic review [Texte imprimé et/ou numérique] / Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Jessica PAPPAGIANOPOULOS, Auteur ; Robert CROSS, Auteur ; Roma A. VASA, Auteur ; Micah O. MAZUREK, Auteur . - 102068. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 99 (November) . - 102068 Mots-clés : Autism  ASD  Anxiety  Mental health  Treatment Index. décimale : PER Périodiques Résumé : Background Autistic adults are more likely than adults without autism spectrum disorder (ASD) to experience clinically significant anxiety. In addition, anxiety in autistic adults is associated with poorer quality of life and myriad negative outcomes (e.g., unemployment, suicidality). Therefore, this systematic review aimed to summarize and evaluate the literature on the psychotherapeutic and psychopharmacological treatment of anxiety in autistic adults to inform clinical decision-making. Method Several online databases were searched for peer-reviewed journal articles with any combination of the following terms in the abstract: (1) autism, autistic, Asperger, Asperger’s, or œpervasive developmental disorder � (2) anxiety, anxious, phobia, mutism, panic, agoraphobia, or worry and (3) treatment, intervention, trial, therapy, psychotherapy, pharmacotherapy, medication, drug, antidepressant, sedative, or anti-anxiety. Data were extracted from articles meeting the inclusion criteria, and the strength of the evidence was assessed for treatments. Results Fifteen psychosocial treatment studies, one pharmacological treatment study, and one combined psychosocial and pharmacological treatment study met the inclusion criteria. The most investigated treatment for anxiety in adults with ASD was cognitive behavioral therapy (CBT). Conclusions Few studies have investigated the treatment of anxiety in autistic adults. Additionally, findings have been inconsistent across studies regarding the potential effectiveness of particular psychosocial and pharmacological treatments. More research is certainly needed before clinically useful conclusions can be made. En ligne : https://doi.org/10.1016/j.rasd.2022.102068 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=491

Treatment of Depression in Individuals with Autism Spectrum Disorder: A Systematic Review / Michelle MENEZES in Research in Autism Spectrum Disorders, 78 (October 2020)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 78 (October 2020) . - 101639 Titre : Treatment of Depression in Individuals with Autism Spectrum Disorder: A Systematic Review Type de document : Texte imprimé et/ou numérique Auteurs : Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Micah O. MAZUREK, Auteur Article en page(s) : 101639 Langues : Anglais (eng) Mots-clés : autism spectrum disorder  depression  psychiatric comorbidity  treatment  ASD  therapy Index. décimale : PER Périodiques Résumé : Background Given the prevalence of depression in persons with autism spectrum disorder (ASD), effective treatment is crucial; however, a systemic review on the topic has not been published in over a decade. This study aimed to systematically examine the efficacy of psychosocial and pharmacological treatments for depression in youth and adults with ASD to inform clinical practice. Method PsycINFO, PubMed, and CINAHL online databases were searched for peer-reviewed journal articles containing any combination of the following terms in the abstract: (1) autism, autistic, Asperger, or “pervasive developmental disorder,” (2) depression or depressive and (3) treatment, intervention, trial, therapy, medication, drug, or antidepressant. Evidence from studies meeting the predetermined criteria of inclusion was assessed for its strength to inform clinical decision-making. Results Twenty psychosocial treatment studies and five pharmacological treatment studies met the criteria of inclusion. Psychosocial interventions studied the effectiveness of cognitive remediation therapy, behavioral therapy, cognitive-behavioral therapy (CBT), combined psychosocial intervention, mindfulness-based therapy (MBT), and social, academic, and/or vocational skills training. Pharmacological interventions studied the effectiveness of anti-epileptic drug, norepinephrine reuptake inhibitor, stimulant, atypical antipsychotic, and NMDA receptor antagonist treatment. Conclusions Although much recent research has investigated potentially effective treatments for depression in individuals with ASD, the strength of the evidence remains generally poor. However, studies indicate preliminary efficacy for MBT. A number of investigations have examined the effect of CBT on depression in persons with ASD; however, the results are inconsistent. Further research is needed to advance clinical practice for individuals with ASD and comorbid depression. En ligne : https://doi.org/10.1016/j.rasd.2020.101639 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=433 [article] Treatment of Depression in Individuals with Autism Spectrum Disorder: A Systematic Review [Texte imprimé et/ou numérique] / Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Micah O. MAZUREK, Auteur . - 101639. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 78 (October 2020) . - 101639 Mots-clés : autism spectrum disorder  depression  psychiatric comorbidity  treatment  ASD  therapy Index. décimale : PER Périodiques Résumé : Background Given the prevalence of depression in persons with autism spectrum disorder (ASD), effective treatment is crucial; however, a systemic review on the topic has not been published in over a decade. This study aimed to systematically examine the efficacy of psychosocial and pharmacological treatments for depression in youth and adults with ASD to inform clinical practice. Method PsycINFO, PubMed, and CINAHL online databases were searched for peer-reviewed journal articles containing any combination of the following terms in the abstract: (1) autism, autistic, Asperger, or “pervasive developmental disorder,” (2) depression or depressive and (3) treatment, intervention, trial, therapy, medication, drug, or antidepressant. Evidence from studies meeting the predetermined criteria of inclusion was assessed for its strength to inform clinical decision-making. Results Twenty psychosocial treatment studies and five pharmacological treatment studies met the criteria of inclusion. Psychosocial interventions studied the effectiveness of cognitive remediation therapy, behavioral therapy, cognitive-behavioral therapy (CBT), combined psychosocial intervention, mindfulness-based therapy (MBT), and social, academic, and/or vocational skills training. Pharmacological interventions studied the effectiveness of anti-epileptic drug, norepinephrine reuptake inhibitor, stimulant, atypical antipsychotic, and NMDA receptor antagonist treatment. Conclusions Although much recent research has investigated potentially effective treatments for depression in individuals with ASD, the strength of the evidence remains generally poor. However, studies indicate preliminary efficacy for MBT. A number of investigations have examined the effect of CBT on depression in persons with ASD; however, the results are inconsistent. Further research is needed to advance clinical practice for individuals with ASD and comorbid depression. En ligne : https://doi.org/10.1016/j.rasd.2020.101639 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=433

---

1 (1 - 2 / 2)